Inspire Medical Systems Total Liabilities and Share Holders Equity 2017-2024 | INSP
Inspire Medical Systems total liabilities and share holders equity from 2017 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
- Inspire Medical Systems total liabilities and share holders equity for the quarter ending September 30, 2024 was $0.796B, a 24.5% increase year-over-year.
- Inspire Medical Systems total liabilities and share holders equity for 2023 was $0.677B, a 19.82% increase from 2022.
- Inspire Medical Systems total liabilities and share holders equity for 2022 was $0.565B, a 91.43% increase from 2021.
- Inspire Medical Systems total liabilities and share holders equity for 2021 was $0.295B, a 4.94% increase from 2020.
| Inspire Medical Systems Annual Total Liabilities and Share Holders Equity (Millions of US $) |
|
|---|---|
| 2023 | $677 |
| 2022 | $565 |
| 2021 | $295 |
| 2020 | $281 |
| 2019 | $181 |
| 2018 | $200 |
| 2017 | $25 |
| 2016 | $0 |
| Inspire Medical Systems Quarterly Total Liabilities and Share Holders Equity (Millions of US $) |
|
|---|---|
| 2024-09-30 | $796 |
| 2024-06-30 | $728 |
| 2024-03-31 | $686 |
| 2023-12-31 | $677 |
| 2023-09-30 | $639 |
| 2023-06-30 | $618 |
| 2023-03-31 | $572 |
| 2022-12-31 | $565 |
| 2022-09-30 | $528 |
| 2022-06-30 | $292 |
| 2022-03-31 | $290 |
| 2021-12-31 | $295 |
| 2021-09-30 | $279 |
| 2021-06-30 | $272 |
| 2021-03-31 | $273 |
| 2020-12-31 | $281 |
| 2020-09-30 | $272 |
| 2020-06-30 | $271 |
| 2020-03-31 | $166 |
| 2019-12-31 | $181 |
| 2019-09-30 | $183 |
| 2019-06-30 | $186 |
| 2019-03-31 | $190 |
| 2018-12-31 | $200 |
| 2018-09-30 | $131 |
| 2018-06-30 | $134 |
| 2018-03-31 | $28 |
| 2017-12-31 | $25 |
| 2017-09-30 | $0 |
| 2017-06-30 | $0 |
| 2017-03-31 | $0 |
| 2016-12-31 | $0 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $5.693B | $0.625B |
| Inspire Medical Systems Inc. is a medical technology company. It focused on the development and commercialization of solutions for obstructive sleep apnea. The company's proprietary Inspire therapy is a neurostimulation technology which provides treatment for moderate to severe obstructive sleep apnea. Inspire Medical Systems Inc.is based in Minnesota, United States. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $37.714B | 55.57 |
| Tempus AI (TEM) | United States | $7.994B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $6.961B | 177.00 |
| IRhythm Technologies (IRTC) | United States | $3.453B | 0.00 |
| Privia Health (PRVA) | United States | $2.701B | 225.10 |
| Enovis (ENOV) | United States | $2.693B | 17.94 |
| Azenta (AZTA) | United States | $2.440B | 130.24 |
| Clover Health Investments (CLOV) | United States | $2.230B | 0.00 |
| Omnicell (OMCL) | United States | $2.070B | 67.71 |
| Schrodinger (SDGR) | United States | $1.819B | 0.00 |
| 10x Genomics (TXG) | United States | $1.796B | 0.00 |
| Phreesia (PHR) | United States | $1.669B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.748B | 0.00 |
| Standard BioTools (LAB) | United States | $0.588B | 0.00 |
| Talkspace (TALK) | United States | $0.537B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.515B | 0.00 |
| TruBridge (TBRG) | United States | $0.362B | 105.43 |
| Nyxoah SA (NYXH) | Belgium | $0.354B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.343B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.235B | 0.00 |
| Pulmonx (LUNG) | United States | $0.230B | 0.00 |
| American Well (AMWL) | United States | $0.169B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.096B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.069B | 0.00 |
| CareCloud (CCLD) | United States | $0.058B | 0.00 |
| HeartBeam (BEAT) | United States | $0.058B | 0.00 |
| 111 (YI) | China | $0.047B | 0.00 |
| Outset Medical (OM) | United States | $0.044B | 0.00 |
| Zepp Health (ZEPP) | China | $0.042B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.042B | 0.00 |
| Zhongchao (ZCMD) | China | $0.035B | 0.00 |
| Movano (MOVE) | United States | $0.034B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.020B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.018B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.014B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.012B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Syra Health (SYRA) | United States | $0.005B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |